Proxidrugs – Cluster4Future

Proxidrugs – Cluster4Future company information, Employees & Contact Information

PROXIDRUGS is funded as part of the Clusters4Future Initiative by the German Federal Ministry of Education and Research (BMBF) since 2021. The cluster focuses on developing new treatments for diseases with high unmet medical needs by utilizing the new concept of targeted protein degradation. Proximity-inducing drugs can trigger the degradation of disease-relevant proteins in a highly specific manner by directing them towards the cellular recycling system. That will open up new therapeutic options in a broad spectrum of diseases. PROXIDRUGS aims at improving this novel class of drugs in multiple ways: the strategy comprises the identification of suitable functional subunits for molecule engineering; the directed optimization of pharmacological properties; and the transfer to clinical phases. In line with this, the cluster interlinks partners from academia and industry, covering the entire value chain from basic to translational research.

Company Details

Employees
1
Address
Theodor-Stern-Kai 7, Frankfurt Am Main,60590,germany
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Frankfurt am Main
Looking for a particular Proxidrugs – Cluster4Future employee's phone or email?

Proxidrugs – Cluster4future Questions

Top Proxidrugs – Cluster4Future Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant